Marshall Islands vs Seychelles: Hepatitis B surface antigen (HBsAg) prevalence
Marshall Islands
0.9%
in 2024
Seychelles
0.8%
in 2024
Marshall Islands rank
36th
Seychelles rank
39th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Marshall Islands
- Seychelles
How they compare
Marshall Islands currently reports 0.9% against 0.8% in Seychelles, a difference of 0.1%.
That makes Marshall Islands's figure about 1.1 times Seychelles's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Seychelles ahead.
Marshall Islands ranks 36th and Seychelles ranks 39th of 194 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.2% | 0.1% | Marshall Islands |
| 2020s | 1.0% | 0.8% | 0.2% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Marshall Islands or Seychelles?
- Marshall Islands, at 0.9% against 0.8% in Seychelles as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Marshall Islands and Seychelles?
- 0.1%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Seychelles?
- 10 years are reported by both, from 2015 to 2024.
- How do Marshall Islands and Seychelles rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Marshall Islands ranks 36th and Seychelles ranks 39th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.